Value proposition
Mitochondrial modulators for weight loss with muscle protection in obesity-related indications.
MitoRx Therapeutics is a preclinical stage platform biotech developing a new category of innovative small molecule mitochondrial metabolic modulators for weight loss with muscle protection in obesity-related indications and metabolic disease.
mitochondrial disease, neuromuscular disease, biotech, preclinical, drug discovery, mitochondria, MitoRx, muscular dystrophy, neurodegenerative disease, first-in-class, obesity, diabetes, muscle preservation, cardiometabolic, muscle protection, and weight loss
MitoRx Therapeutics - First-in-class mitochondrial protective therapeutics
Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. Mito Rx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
https://www.mitorxtherapeutics.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Other | ||
 Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Other 9 Jan 2025 | | |
 Sifted Newspaper Publishing | Sifted Newspaper Publishing | Other 30 Sep 2023 | | |